Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- IMpower130
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Cancer Lung Cancer Non-Small Cell Lung Cancer (NSCLC)
- Results
-
Download -
Study results
LPS GO29537 IMpower130 Final Results February 2021 Arabic
(PDF, 1.0 MB)
LPS GO29537 IMpower130 Final Results February 2021 Dutch Belgium
(PDF, 1.0 MB)
LPS GO29537 IMpower130 Final Results February 2021 English
(PDF, 0.9 MB)
LPS GO29537 IMpower130 Final Results February 2021 French France
(PDF, 1.0 MB)
LPS GO29537 IMpower130 Final Results February 2021 German
(PDF, 0.9 MB)
LPS GO29537 IMpower130 Final Results February 2021 Hebrew
(PDF, 1.0 MB)
LPS GO29537 IMpower130 Final Results February 2021 Italian
(PDF, 0.9 MB)
LPS GO29537 IMpower130 Final Results February 2021 Russian
(PDF, 1.0 MB)
LPS GO29537 IMpower130 Final Results February 2021 Spanish Spain
(PDF, 0.9 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com